US Patents for PCT: WO2005/054215
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vanda Pharms Inc | PONVORY | ponesimod | TABLET;ORAL | 213498-001 | Mar 18, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | |||
Vanda Pharms Inc | PONVORY | ponesimod | TABLET;ORAL | 213498-002 | Mar 18, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | |||
Vanda Pharms Inc | PONVORY | ponesimod | TABLET;ORAL | 213498-003 | Mar 18, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | |||
Vanda Pharms Inc | PONVORY | ponesimod | TABLET;ORAL | 213498-004 | Mar 18, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use |